OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Neuropsychiatric Drugs Against COVID-19: What is the Clinical Evidence?
Juliane K. Mueller, Peter Riederer, Wernér E.G. Müller
Pharmacopsychiatry (2022) Vol. 55, Iss. 01, pp. 7-15
Open Access | Times Cited: 18
Juliane K. Mueller, Peter Riederer, Wernér E.G. Müller
Pharmacopsychiatry (2022) Vol. 55, Iss. 01, pp. 7-15
Open Access | Times Cited: 18
Showing 18 citing articles:
Multi-target drugs for the treatment of cognitive impairment and fatigue in post-COVID syndrome: focus on Ginkgo biloba and Rhodiola rosea
Juliane K. Mueller, Walter E. Müller
Journal of Neural Transmission (2024) Vol. 131, Iss. 3, pp. 203-212
Open Access | Times Cited: 5
Juliane K. Mueller, Walter E. Müller
Journal of Neural Transmission (2024) Vol. 131, Iss. 3, pp. 203-212
Open Access | Times Cited: 5
The Multisystem effects of Long COVID Syndrome and Potential Benefits of Massage Therapy in Long COVID Care
Elias Wheibe, Benjamin H. Dalkin, Haley C. Meltzer, et al.
International Journal of Therapeutic Massage & Bodywork Research Education & Practice (2024) Vol. 17, Iss. 1, pp. 19-42
Open Access | Times Cited: 3
Elias Wheibe, Benjamin H. Dalkin, Haley C. Meltzer, et al.
International Journal of Therapeutic Massage & Bodywork Research Education & Practice (2024) Vol. 17, Iss. 1, pp. 19-42
Open Access | Times Cited: 3
How Do Liquid-Junction Potentials and Medium Polarity at Electrode Surfaces Affect Electrochemical Analyses for Charge-Transfer Systems?
Maximillian F. Mayther, Omar O’Mari, Paul Flacke, et al.
The Journal of Physical Chemistry B (2023) Vol. 127, Iss. 6, pp. 1443-1458
Open Access | Times Cited: 7
Maximillian F. Mayther, Omar O’Mari, Paul Flacke, et al.
The Journal of Physical Chemistry B (2023) Vol. 127, Iss. 6, pp. 1443-1458
Open Access | Times Cited: 7
Chlorpromazine, a Clinically Approved Drug, Inhibits SARS-CoV-2 Nucleocapsid-Mediated Induction of IL-6 in Human Monocytes
Iwona Karwaciak, Kaja Karaś, Anna Sałkowska, et al.
Molecules (2022) Vol. 27, Iss. 12, pp. 3651-3651
Open Access | Times Cited: 10
Iwona Karwaciak, Kaja Karaś, Anna Sałkowska, et al.
Molecules (2022) Vol. 27, Iss. 12, pp. 3651-3651
Open Access | Times Cited: 10
Selective serotonin reuptake inhibitors and preeclampsia: A quality assessment and meta-analysis
Serena B. Gumusoglu, Brandon Schickling, Julie Vignato, et al.
Pregnancy Hypertension (2022) Vol. 30, pp. 36-43
Open Access | Times Cited: 10
Serena B. Gumusoglu, Brandon Schickling, Julie Vignato, et al.
Pregnancy Hypertension (2022) Vol. 30, pp. 36-43
Open Access | Times Cited: 10
Psychiatric manifestations of post-COVID-19 syndrome: the potential benefit of Silexan
Siegfried Kasper, Anne Eckert, Hans‐Jürgen Möller, et al.
International Journal of Psychiatry in Clinical Practice (2023) Vol. 27, Iss. 3, pp. 285-291
Open Access | Times Cited: 5
Siegfried Kasper, Anne Eckert, Hans‐Jürgen Möller, et al.
International Journal of Psychiatry in Clinical Practice (2023) Vol. 27, Iss. 3, pp. 285-291
Open Access | Times Cited: 5
Psychopharmacotherapy factor in the variants of COVID-19 course in psychiatric inpatients
Н. Г. Незнанов, О. В. Лиманкин, A. V. Shabelnik, et al.
V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY (2024) Vol. 58, Iss. 2, pp. 79-88
Open Access | Times Cited: 1
Н. Г. Незнанов, О. В. Лиманкин, A. V. Shabelnik, et al.
V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY (2024) Vol. 58, Iss. 2, pp. 79-88
Open Access | Times Cited: 1
Infections and mental diseases: from tuberculosis to COVID-19
Janusz Rybakowski
Psychiatria Polska (2022) Vol. 56, Iss. 5, pp. 931-944
Open Access | Times Cited: 6
Janusz Rybakowski
Psychiatria Polska (2022) Vol. 56, Iss. 5, pp. 931-944
Open Access | Times Cited: 6
Effect of fluvoxamine on outcomes of nonhospitalized patients with COVID-19: A systematic review and meta-analysis
Li‐Chin Lu, Chien‐Ming Chao, Shen-Peng Chang, et al.
Journal of Infection and Public Health (2022) Vol. 15, Iss. 11, pp. 1259-1264
Open Access | Times Cited: 4
Li‐Chin Lu, Chien‐Ming Chao, Shen-Peng Chang, et al.
Journal of Infection and Public Health (2022) Vol. 15, Iss. 11, pp. 1259-1264
Open Access | Times Cited: 4
Comparable Psychotropic Prescription Rates After Hospital Discharge Between Patients with COVID-19 and Those With Non-COVID-19-Related Respiratory Infection
Yuna Takahashi, Taisuke Yatomi, Naohito Yamaguchi, et al.
Pharmacopsychiatry (2024) Vol. 57, Iss. 04, pp. 186-190
Closed Access
Yuna Takahashi, Taisuke Yatomi, Naohito Yamaguchi, et al.
Pharmacopsychiatry (2024) Vol. 57, Iss. 04, pp. 186-190
Closed Access
Understanding the etiology of mental health problems in post-rehabilitation COVID-19 patients: Insights and strategies for effective intervention
Haisheng Hu, Baoqing Sun
World Journal of Clinical Cases (2024) Vol. 12, Iss. 23, pp. 5308-5312
Open Access
Haisheng Hu, Baoqing Sun
World Journal of Clinical Cases (2024) Vol. 12, Iss. 23, pp. 5308-5312
Open Access
News on the Role of Antidepressants in and for COVID-19 and Long COVID
Udo Bonnet, Georg Juckel
Pharmacopsychiatry (2024)
Closed Access
Udo Bonnet, Georg Juckel
Pharmacopsychiatry (2024)
Closed Access
Prevalence of COVID-19 and Psychotropic Drug Treatment in Psychiatric In-patients in Germany in 2020: Results from a Nationwide Pilot Survey
Juliane K. Mueller, Kira F. Ahrens, Michael Bauer, et al.
Pharmacopsychiatry (2023) Vol. 56, Iss. 06, pp. 227-238
Closed Access | Times Cited: 1
Juliane K. Mueller, Kira F. Ahrens, Michael Bauer, et al.
Pharmacopsychiatry (2023) Vol. 56, Iss. 06, pp. 227-238
Closed Access | Times Cited: 1
SSRIs in the course of COVID‐19 pneumonia: Evidence of effectiveness of antidepressants on acute inflammation. A retrospective study
Leonardo Fei, Bernardo Bozza, Giulia Melani, et al.
Human Psychopharmacology Clinical and Experimental (2023)
Closed Access | Times Cited: 1
Leonardo Fei, Bernardo Bozza, Giulia Melani, et al.
Human Psychopharmacology Clinical and Experimental (2023)
Closed Access | Times Cited: 1
Review of: "[Case Report] Supplementation with Vitamin D, Zinc, and Quercetin to Treat COVID-19: A Case Report"
Walter Erhard Mueller
(2023)
Open Access
Walter Erhard Mueller
(2023)
Open Access
Covid-19: Contributions from Psychopharmacology
Michael Bauer, Georg Juckel
Pharmacopsychiatry (2022) Vol. 55, Iss. 01, pp. 5-6
Closed Access
Michael Bauer, Georg Juckel
Pharmacopsychiatry (2022) Vol. 55, Iss. 01, pp. 5-6
Closed Access
Use of Psychotropics in COVID-19: Another Anti-inflammatory Pathway
Jessenia Morillo, Valery Morillo, María A. Marquina, et al.
Current Psychiatry Research and Reviews (2022) Vol. 19, Iss. 2, pp. 137-146
Closed Access
Jessenia Morillo, Valery Morillo, María A. Marquina, et al.
Current Psychiatry Research and Reviews (2022) Vol. 19, Iss. 2, pp. 137-146
Closed Access
The effect of psychotropic drugs on the occurrence and course of COVID-19
Janusz Rybakowski
Pharmacotherapy in Psychiatry and Neurology (2022) Vol. 38, Iss. 1, pp. 9-21
Open Access
Janusz Rybakowski
Pharmacotherapy in Psychiatry and Neurology (2022) Vol. 38, Iss. 1, pp. 9-21
Open Access
